Swantje I. Hammerschmidt

Hannover, NI, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Isoform-Level Analysis Reveals Reproducible Early Changes in Transcript Usage During Human Vaccine Responses.

Isoform-Level Analysis Reveals Reproducible Early Changes in Transcript Usage During Human Vaccine Responses.

Journal: European journal of immunology
Published: June 02, 2026

Blood transcriptome profiling reveals distinct gene networks induced by mRNA vaccination against COVID-19.

Blood transcriptome profiling reveals distinct gene networks induced by mRNA vaccination against COVID-19.

Journal: European journal of immunology
Published: May 02, 2024

Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination.

Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination.

Journal: The Lancet. Infectious diseases
Published: October 12, 2023

Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine.

Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine.

Journal: EBioMedicine
Published: August 24, 2023

Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals.

Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals.

Journal: Frontiers in immunology
Published: February 15, 2023

Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of Concern.

Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of Concern.

Journal: Frontiers in immunology
Published: January 26, 2022

BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19.

BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19.

Journal: Nature communications
Published: December 24, 2021

Imaging dendritic cell functions.

Imaging dendritic cell functions.

Journal: Immunological reviews
Published: October 25, 2021

Robust induction of neutralizing antibodies against the SARS-CoV-2 Delta variant after homologous Spikevax or heterologous Vaxzevria-Spikevax vaccination.

Robust induction of neutralizing antibodies against the SARS-CoV-2 Delta variant after homologous Spikevax or heterologous Vaxzevria-Spikevax vaccination.

Journal: European journal of immunology
Published: September 20, 2021

Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents.

Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents.

Journal: Frontiers in immunology
Published: September 07, 2021

Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination.

Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination.

Journal: Cellular & molecular immunology
Published: July 29, 2021

Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.

Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.

Journal: Nature medicine
Published: June 01, 2021
Showing 1-12 of 16

Last Updated: 09/26/2026